Health & Fitness

LOCATION. WHAT ARE YOU LEARNING TONIGHT? DAMON: IT'S THEIR LOCATION HERE ON PORTLAND -- DILLON: IT'S THEIR LOCATION HERE ON PORTLAND. THERE'S ACTIVITY IN THE PARKING LOT. WE KNOW THEY'RE OPEN MANAGER BEDS FOR COVID PATIENT HERE'S AS SOME OF THEIR OTHER LOCATIONS, PARTICULARLY THE ONE ON NORTHWEST EXPRESS WAY, STARTS TO APPROACH CAPACITY. >> WE ARE STARTING TO BUMP UP AGAINST CAPACITY, ABSLEWLY. DILLON: TONIGHT TOP INTEGRIS HEALTH OFFICIALS REPORT MORE PREPARATIONS UNDER WAY OUTSIDE THE PORTLAND LOCATION AS THEY START TO OPEN FOR MORE BEDS HERE INSIDE THE COVID UNIT'S INTENSE DIFFICULT WORK. >> YOU'RE IN THE TRENCHES. YOU'RE TRYING TO PULL THESE PATIENTS THROUGH. IT REQUIRES A TREMENDOUS AMOUNT OF INGENUITY AND ADAPTATION BECAUSE YOU'RE TRYING TO COMMUNICATION WITH F...

A HIV-positive man in remission may be the first patient effectively cured of the illness without needing a bone marrow transplant, researchers said Tuesday in a potential breakthrough.   HIV affects tens of millions of people globally and while the disease is no longer the automatic death sentence it once was, patients need to take medication for life. In recent years two men - known as the "Berlin" and "London" patients - appear to have been cured of the disease after undergoing high-risk stem cell bone marrow transplants to treat cancer. Now an international team of researchers believe they may have a third patient who no longer shows sign of infection after undergoing a different medicine regimen. The patient, a 34-year-old Brazilian who has not been named, was diagnosed with HIV...

PARIS (AFP) — Potentially fatal COVID-19 complications in the brain including delirium, nerve damage and stroke may be more common than initially thought, a team of British-based doctors warned Wednesday. Severe COVID-19 infections are known to put patients at risk of neurological complications, but research led by University College London suggests serious problems can occur even in individuals with mild cases of the virus. The team looked at the neurological symptoms of 43 patients hospitalized with either confirmed or suspected COVID-19. Get The Times of Israel's Daily Edition by email and never miss our top stories Free Sign Up They found 10 cases of temporary ...

Lysol is the first surface disinfectant approved by the Environmental Protection Agency to wipe out the coronavirus.  Two versions of the common household disinfectant spray were lab tested by the agency, which found they could kill the virus on surfaces, the EPA announced. Lysol Disinfectant Spray, priced at $4.18 at Walmart, and Lysol Disinfectant Max Cover Mist, priced at $5.48, can kill the virus in under 2 minutes, the agency found.  "The EPA's approval recognizes that using Lysol Disinfectant Spray can help to prevent the spread of COVID-19 on hard, non-porous surfaces," said Rahul Kadyan, executive vice president of hygiene for Lysol's parent company Reckitt Benckiser in a statement. Save better, spend better:Money tips and advice delivered right to your inbox. Sign up here "In...

...

Texas, Florida and Arizona are now seeing an increase in COVID-19 deaths at least two weeks after the hot spot states first started seeing record spikes in cases. It comes as the United States set a grim record on Tuesday with more than 60,000 new coronavirus cases reported in a single day, up from the previous record of 53,600 infections set last Thursday. The number of cases across the US is now nearing 3 million and more than 131,000 Americans have died from COVID-19 since the pandemic took hold in March. At least 1,100 of those deaths were recorded on Tuesday, which is the highest daily increase this month. Deaths across the country have been trending downwards even as the number of infections surge to levels not seen throughout the pandemic. But the fatality rates in Texas, Arizona a...

This light micrograph from the brain of someone who died with Alzheimer's disease shows the plaques and neurofibrillary tangles that are typical of the disease. A glitch that prevents healthy cell structures from transitioning from one phase to the next might contribute to the tangles, researchers say. Jose Luis Calvo/ Science Source hide caption toggle caption Jose Luis Calvo/ Science Source This light micrograph from the brain of someone who died w...

Paris (AFP) - Potentially fatal COVID-19 complications in the brain including delirium, nerve damage and stroke may be more common than initially thought, a team of British-based doctors warned Wednesday. Severe COVID-19 infections are known to put patients at risk of neurological complications, but research led by University College London suggests serious problems can occur even in individuals with mild cases of the virus. The team looked at the neurological symptoms of 43 patients hospitalised with either confirmed or suspected COVID-19. They found 10 cases of temporary brain dysfunction, 12 cases of brain inflammation, eight strokes and eight cases of nerve damage. Most of those patients with inflammation were diagnosed with acute disseminated encephalomyelitis (ADEM) -- a rare condit...

A safe and effective vaccine would be a shot in the arm for a world that's grown weary of the COVID-19 pandemic. The good news is that there's a lot of work going on to produce just such a vaccine. At least 19 novel-coronavirus vaccine candidates are now in clinical testing, according to the World Health Organization (WHO). Another 130 candidates are currently in preclinical trials. But you shouldn't get your hopes too high for COVID-19 vaccines. Here are three reasons why. Image source: Getty Images. 1. The probability of success isn't as great as you might think Many Americans assume that regulatory approval of a vaccine is right around the corner. President Donald Trump even publicly suggested that a "vaccine solution" for COVID-19 will be available "long before the end of the year...

Vaccines don't act as impenetrable shields that prevent viruses from entering our bodies. Rather, they teach our bodies how to rapidly mobilize our immune defenses against a foreign invader. The rapid immune response helps us clear the virus from the body before it wreaks its damage. But in the case of Covid-19, according to one study, not everybody infected by the virus makes the neutralizing antibodies that are necessary to clear the virus and fewer still make them in high numbers. What we know from nearly 60 years of observing coronaviruses is that even if a body's immune system can clear the virus, the pathogen can likely reenter the system and cause illness again. Of the more than 100 vaccines currently in development, the ones tested on primates have not prevented nasal infe...